Related Experiment Videos
Efficient expression system of human recombinant laminin-5
Yoshinobu Kariya1, Kumiko Ishida, Yoshiaki Tsubota
1Division of Cell Biology, Kihara Institute for Biological Research and Graduate School of Integrated Sciences, Yokohama City University, Maioka-cho, Totsuka-ku, Yokohama 244-0813, Japan. miyazaki@yokohama-cu.ac.jp
Journal of Biochemistry
|October 3, 2002
Summary
Researchers developed an efficient system to produce human recombinant laminin-5 (rLN5), a key protein for cell adhesion. This new method yields significantly more rLN5 than natural sources, offering potential for regenerative medicine.
Area of Science:
- Biochemistry
- Cell Biology
- Biotechnology
Background:
- Laminin-5 (LN5) is crucial for epithelial basement membranes, promoting cell adhesion and motility.
- Understanding LN5's structure and function is vital for tissue regeneration.
Purpose of the Study:
- To establish an efficient expression system for human recombinant laminin-5 (rLN5).
- To characterize the biological activity and subunit interactions of rLN5.
- To explore potential applications of rLN5 in regenerative medicine.
Main Methods:
- Full-length cDNAs for human laminin alpha3, beta3, and gamma2 chains were introduced into HEK293 cells.
- Recombinant LN5 (rLN5) was purified using immuno-affinity chromatography.
- Subunit association was analyzed in HEK293 transfectants expressing pairs of LN5 subunits.
Main Results:
- An efficient expression system yielded 1 mg/L of rLN5, 10 times higher than natural sources.
- Purified rLN5 demonstrated indistinguishable protein composition and biological activity compared to natural LN5.
- Gamma2 chain is essential for the assembly of the three LN5 subunits, with alpha3/gamma2 and beta3/gamma2 heterodimers being secreted.
Conclusions:
- The developed rLN5 expression system is highly efficient and produces biologically active protein.
- The gamma2 chain plays a critical role in LN5 heterotrimer formation.
- This system provides a valuable tool for studying LN5 functions and advancing regenerative medicine applications.